Yizhuo Zhang

Corporate Directors Forum operates as a forum for corporate directors. The non-profit company is based in La Jolla, CA.

BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA.

Museum of Science operates as a museum. The company was founded in 1830 and is headquartered in Boston, MA.

Beryllium LLC p. engages in the research and development of pharmaceutical products. It offers structural biology services. The company was founded by Johan Pontin in 2009 and is headquartered in Bainbridge Island, WA.

Massachusetts Life Sciences Center functions as a pension/retirement fund. The private company is based in Waltham, MA. The CEO of the company is Kenn Turner.

Sentebale provides psychological support services for children living with HIV. The British company was founded in 2006 by Prince Seeiso. The CEO is Cathy Ferrier.

Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company was founded in 2008 and is headquartered in Lexington, MA.

The Association for Women in Science is an organization that supports and recognizes women in science, technology, engineering, and mathematics. The non-profit company is based in Washington. The organization provides a central repository for articles, blogs, press releases, webinars, videos, and newsletters, as well as curated content for women in STEM. The organization also educates about Title IX protections and how to report violations. The AWIS Wall of WISdom provides inspiration and advice from other women in science and STEM. Meredith R. Gibson has been the CEO of the American company since 2022.

Schering-Plough Research Institute provides pharmaceutical research. The company is headquartered in Kenilworth, NJ.

Part of Merck & Co., Inc., Canji, Inc. is a gene therapy research company. The company is based in San Diego, CA. Canji was acquired by Schering-Plough Corp., part of Merck & Co., Inc. from November 03, 2009 on February 02, 1996 for $54.50 million.

Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company.

Biomedical Growth Strategies LLC provides strategic advisory services. The private company is based in Carlise, MA. Susan R. Windham-Bannister has been the CEO of the company since 2015.

Longwood Fund Management LLC (Longwood Fund) is a venture capital firm founded in 2010 by Christoph H. Westphal, Michelle Detwiler and Richard H. Aldrich. The firm is headquartered in Boston, Massachusetts.

SanBio, Inc. develops regenerative therapies for neurological disorders. The firm is focused on cell therapies for neurological disorders such as stroke, traumatic brain injury, eye disease, and Parkinson's disease. Its product pipeline includes SB623 and SB618. The company was founded by Keita Mori and Toru Kawanishi in 2001 and is headquartered in Mountain View, CA.

Point32Health, Inc. is a health and wellbeing organization that provides affordable and high-quality health care to its 2 million members. The non-profit company is based in Watertown, MA, and has subsidiaries in the United States. The company offers a diverse range of health plans that cater to the needs of its members, regardless of their age, race, ethnicity, socioeconomic status, orientation, gender identity, or ability. Point32Health is one of the top twenty health plans in the United States and builds on the quality of its founding organizations, Tufts Health Plan and Harvard Pilgrim Health Care. Cain A. Hayes has been the CEO of the company since 2021.

Financial Industry Regulatory Authority, Inc. engages in the provision of securities regulation, complementary compliance, and technology-based services. Its services include writing and enforcing rules governing the activities of securities firms with brokers, examining firms for compliance with those rules, fostering market transparency, and educating investors. The company was founded in 2007 and is headquartered in Washington, DC.

The Abt Bio-Pharma Solutions team has provided integrated strategic, research, and communications services to the pharmaceutical, biotechnology, medical device, and diagnostics industries for 25 years. Its parent company, Abt Associates Inc., is one of the largest research and consulting firms in the world, applying scientific expertise to a wide range of health, economic, social, environmental, and technological policy issues. Founded in 1965, Abt Associates has annual revenue in excess of $200 million and a staff of more than 1,000, including national and international experts who are recognized for their knowledge, innovative research techniques, and insightful analysis & recommendations. In the early 1980s, Abt Associates' staff of bio statisticians, clinicians, health economists, and strategic consultants began designing, analyzing, and reporting on clinical trials for a broad variety of drugs and devices covering many therapeutic areas. Over the next decade, their services for commercial sponsors grew to include registries and other real world studies designed to evaluate safety, efficacy, economic, patient compliance, and health-related quality-of-life factors. The Abt Associates Clinical Trials (AACT) division was created in 1997, combining capabilities in bio-statistics, data management, epidemiology, and clinical trials management. To help sponsors demonstrate product value in a competitive global marketplace, their Health Economic Research and Quality of Life Evaluation Services (HERQuLES) team was established and became a leader in collecting & analyzing data on the use of healthcare products & services and on their clinical, economic, quality of life, and satisfaction outcomes. In recent years, AACT expanded capabilities to include pricing & reimbursement & marketing consulting and research services, employing a cross-functional matrixed approach ideally suited for their clients' multifaceted needs. In April 2008, AACT was renamed Abt Bio-Pharma Solutions and established as a wholly owned subsidiary of Abt Associates. Their new name reflects the full range of custom services they provide to sponsors globally. The ABS team continues Abt Associates' 40-year history of commitment to providing knowledge, delivering insight, and improving world health.

Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA.

St. Jude Children's Research Hospital, Inc. offers health care and social assistance services for children. It is internationally recognized for its pioneering research and treatment for children with cancer and other catastrophic diseases. The firm's treatment programs include brain tumors, leukemia, lymphoma, infectious diseases, immunodeficiency diseases, blood disorders, sickle cell disease, and solid tumors. The company was founded by Danny Thomas on February 4, 1962 and is headquartered in Memphis, TN.

LabCentral, Inc. provides grant making services for bio-tech companies. The firm?s services include maintenance of permits for all lab operations, mandatory EHS training and compliance for all lab users, maintenance of equipment and technical support, CRO support available on-site (FTE basis), cleaning and waste removal. The company was founded by Timothy D. Rowe, Johannes Fruehauf, Peter D. Parker in September 2012 and is headquartered in Cambridge, MA.

Tufts Associated Health Plans, Inc. provides healthcare plans. It offers health care coverage options to individuals and employer groups. The firm also offers choice tiered network option plan and Steward Community Choice, a community-based plan, developed in conjunction with Steward Health Care System. The company was founded by Morton A. Madoff in 1979 and is headquartered in Watertown, MA.

The Securities Investor Protection Corporation either acts as trustee or works with an independent court-appointed trustee in a missing asset case to recover funds. The statute that created SIPC provides that customers of a failed brokerage firm receive all non-negotiable securities that are already registered in their names or in the process of being registered. Recovered funds are used to replenish SIPC's reserve in the event that the reserve is tapped in the early stages of a liquidation proceeding.

Paracrine, Inc. is a biotechnology company that is developing a device-based autologous multifactorial cell therapy platform to treat chronic conditions. The private company is based in San Diego, CA. The company's cell therapy platform has multiple mechanisms of action that can address the underlying pathology of several debilitating chronic diseases. Paracrine is currently advancing multiple late-stage ide clinical trials based on robust prior data. The CEO of the company is Christopher James Calhoun.